U.S. Markets closed

Pfizer Caves In to Trump. Here's Why That's a Bad Thing

barrons.com
Pfizer Caves In to Trump. Here's Why That's a Bad Thing

President Donald Trump has effectively inserted himself into the executive suite of a major pharmaceuticals company. After a presidential tweet Monday that criticized its decision to raise some drug prices, Pfizer (ticker: PFE) said it would postpone the increases. Late Tuesday, Pfizer tweeted that “